Skip to main content


Publication development
for the 21st century.

Forget the tiresome back-and-forth of multi-author publications. Within3 delivers a single place for authors to contribute, engage, and edit manuscripts on any device, from any location. Status updates keep medical writers in the loop, and automatic reminders help authors stay on top of contributions, streamlining the path to publication.


Gain consensus and
build plans

Use virtual discussions before the first draft
of a manuscript to determine direction and
build an outline.


Co-author manuscripts
in real-time

Make comments and edits instantly—and
see your co-authors’ contributions the
second, they’re written.


Built for
author engagement

Automatic status updates and participation
reminders keep authors on top of their
work, so publications stay on schedule.


Learn how a leading drug
company used co-
authoring to shorten
their manuscript

Read the Case Study

Business Results

Shorter timelines

Streamline the path to publication
by bringing all authors into one
virtual platform. Teams that use
Within3 cut their publication
timeline by 33%

Fewer logistical headaches

Co-authoring no longer requires
separate channels of
communication, and real-time
editing removes the back-and-
forth and makes burdensome
collating a thing of the past.

Better engagement

Get authors contributing like
never before. Teams that use
Within3’s platform see superior
author engagement and volume
of contributions.


top 10 pharma resources

Top ten: our most popular posts and resources

December 1, 2023 | Blog | No Comments
Catch up on the industry's most-read articles and resources from 2023.
what is the invisible college

How to reveal the invisible college and pull away from competition

November 8, 2023 | Blog | No Comments
How a hidden network of experts can support your strategy with directional insights.
pharmaceutical industry statistics

New: 6 essential pharmaceutical industry statistics to know in 2024

November 1, 2023 | Blog | No Comments
What major trends and market forces point the way to pharma’s future?

More insights, direct to your inbox.

Get our newsletter.